Title:
ARYLAMINO PYRAMIDINE COMPOUND AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS PREPARED THEREFROM
Document Type and Number:
WIPO Patent Application WO/2015/127873
Kind Code:
A1
Abstract:
Provided are an arylamino pyramidine compound having an inhibiting effect on EGFR tyrosine kinases, and pharmaceutically acceptable salt, stereoisomer, solvent compound, or prodrug of said arylamino pyramidine compound; also provided are pharmaceutical compositions and pharmaceutically acceptable compositions containing the arylamino pyramidine compound, and applications thereof.
Inventors:
LAN JIONG (CN)
CUI YUMIN (CN)
ZHANG LIANG (CN)
JIN YUNZHOU (CN)
ZHOU FUSHENG (CN)
CHENG PENGFEI (CN)
CUI YUMIN (CN)
ZHANG LIANG (CN)
JIN YUNZHOU (CN)
ZHOU FUSHENG (CN)
CHENG PENGFEI (CN)
Application Number:
PCT/CN2015/073045
Publication Date:
September 03, 2015
Filing Date:
February 13, 2015
Export Citation:
Assignee:
SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO LTD (CN)
International Classes:
C07D239/48; A61K31/506; A61K31/5377; A61P3/10; A61P9/00; A61P25/00; A61P35/00; A61P37/02; C07D239/42; C07D401/12
Domestic Patent References:
| WO2015006492A1 | 2015-01-15 |
Foreign References:
| CN102083800A | 2011-06-01 | |||
| CN101035769A | 2007-09-12 | |||
| CN102482277A | 2012-05-30 |
Attorney, Agent or Firm:
XU & PARTNERS,LLC. (CN)
上海一平知识产权代理有限公司 (CN)
上海一平知识产权代理有限公司 (CN)
Download PDF: